跳到正文
原文
Endpoints News· @endpts · X·· 18 天前AI 评分42
AI 导读

在后期临床试验失败的重创下,阿斯利康跟随GSK,推动每年节省15亿美元。https://endpoints.news/astrazeneca-follows-gsk-with-1-5b-annual-savings-push/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial

正文

Battered by late-stage trial failures, AstraZeneca is following GSK with a push to save $1.5B a year. https://endpoints.news/astrazeneca-follows-gsk-with-1-5b-annual-savings-push/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial

来源:Endpoints News · x.com